These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2249982)
21. Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates. Masson P; Xie W; Froment MT; Levitsky V; Fortier PL; Albaret C; Lockridge O Biochim Biophys Acta; 1999 Aug; 1433(1-2):281-93. PubMed ID: 10446378 [TBL] [Abstract][Full Text] [Related]
22. Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion. Stojan J; Golicnik M; Froment MT; Estour F; Masson P Eur J Biochem; 2002 Feb; 269(4):1154-61. PubMed ID: 11856351 [TBL] [Abstract][Full Text] [Related]
23. Two cholinesterase activities and genes are present in amphioxus. Sutherland D; McClellan JS; Milner D; Soong W; Axon N; Sanders M; Hester A; Kao YH; Poczatek T; Routt S; Pezzementi L J Exp Zool; 1997 Feb; 277(3):213-29. PubMed ID: 9062997 [TBL] [Abstract][Full Text] [Related]
24. Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant. Masson P; Adkins S; Gouet P; Lockridge O J Biol Chem; 1993 Jul; 268(19):14329-41. PubMed ID: 8314794 [TBL] [Abstract][Full Text] [Related]
25. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase. Lockridge O; Blong RM; Masson P; Froment MT; Millard CB; Broomfield CA Biochemistry; 1997 Jan; 36(4):786-95. PubMed ID: 9020776 [TBL] [Abstract][Full Text] [Related]
26. Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding. Shafferman A; Kronman C; Flashner Y; Leitner M; Grosfeld H; Ordentlich A; Gozes Y; Cohen S; Ariel N; Barak D J Biol Chem; 1992 Sep; 267(25):17640-8. PubMed ID: 1517212 [TBL] [Abstract][Full Text] [Related]
27. Determination of binding points of methylene blue and cationic phenoxazine dyes on human butyrylcholinesterase. Sezgin Z; Biberoglu K; Chupakhin V; Makhaeva GF; Tacal O Arch Biochem Biophys; 2013 Apr; 532(1):32-8. PubMed ID: 23353050 [TBL] [Abstract][Full Text] [Related]
28. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183 [TBL] [Abstract][Full Text] [Related]
29. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Vellom DC; Radić Z; Li Y; Pickering NA; Camp S; Taylor P Biochemistry; 1993 Jan; 32(1):12-7. PubMed ID: 8418833 [TBL] [Abstract][Full Text] [Related]
31. [Gene analysis of human cholinesterase variants]. Muratani K; Hada T; Higashino K Nihon Rinsho; 1993 Feb; 51(2):495-500. PubMed ID: 8464162 [TBL] [Abstract][Full Text] [Related]
32. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol. Bosak A; Gazić I; Vinković V; Kovarik Z Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304 [TBL] [Abstract][Full Text] [Related]
33. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases. Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273 [TBL] [Abstract][Full Text] [Related]
34. Assay using succinyldithiocholine as substrate: the method of choice for the measurement of cholinesterase catalytic activity in serum to diagnose succinyldicholine sensitivity. Mosca A; Bonora R; Ceriotti F; Franzini C; Lando G; Patrosso MC; Zaninotto M; Panteghini M; Clin Chem Lab Med; 2003 Mar; 41(3):317-22. PubMed ID: 12705341 [TBL] [Abstract][Full Text] [Related]
36. [The peptidase site of butyrylcholinesterase is distinct from the esterase site]. Chatonnet A; Masson P C R Acad Sci III; 1984; 299(13):529-34. PubMed ID: 6208983 [TBL] [Abstract][Full Text] [Related]
37. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis. Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284 [TBL] [Abstract][Full Text] [Related]
38. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase. Biberoglu K; Tacal Ö; Akbulut H Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486 [TBL] [Abstract][Full Text] [Related]
39. [Frequency of locus E1 variants of plasma butyrylcholinesterase in a French population]. Masson P; Germani F; Plasse M C R Seances Acad Sci D; 1979 Oct; 289(6):537-9. PubMed ID: 118816 [TBL] [Abstract][Full Text] [Related]
40. An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes. Simeon-Rudolf V; Kovarik Z; Skrinjarić-Spoljar M; Evans RT Chem Biol Interact; 1999 May; 119-120():159-64. PubMed ID: 10421449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]